Αρχική World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based... World News Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP Από Ogkologos - 22 Σεπτεμβρίου, 2026 128 0 Facebook Twitter Google+ Pinterest WhatsApp Updated results after additional follow-up in the CUPISCO study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study... 7 Ιανουαρίου, 2020 Pausing Long-Term Breast Cancer Therapy to Become Pregnant Appears to Be... 20 Ιανουαρίου, 2023 Rapid, Robust and Durable Antitumour Activity of Pralsetinib in Patients with... 26 Αυγούστου, 2022 Research Says That Your Birth Order Can Shape Your Personality 4 Απριλίου, 2019 Φόρτωση περισσοτέρων HOT NEWS Leveraging Extensive Real-World Data to Systematically Identify Mutations that Predict the... Worse Survival Observed Among Patients Diagnosed with Cancer During the First... Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine... For Hairy Cell Leukemia, Drug Combination Leads to Long-Lasting Remissions